Ranking Invest

ADMA - ADMA Biologics, Inc.

Segmento: HealthcareADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Análise Ranking Invest

Valuation estimado
$ 442.29 Mi
Valor de Mercado
$ 4.16 Bi
Sobrepreço (AV)+840.9%
MLL
0.02A companhia gerou lucro líquido equivalente a 2% do seu valor de mercado nos últimos 4 trimestres.
Último Balanço Atualizado: 1T2025

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 373.42 Mi

Dívida Líquida

$ 10.39 Mi

L4T

$ 206.77 Mi

MM4T

44.63%

Indicadores Básicos

ROE

55.37%

Índices de Previsibilidade

Faturamento

0.16

Lucro

2.24

Margem

0.72

Índices de Tendência

Faturamento

11.62

Lucro

10.59

Margem

10.84

Índices de Endividamento

DIV/PAT

0.03

DIV/L4T

0.05

Dívidas
Cotação
Gráfico Lucro/Faturamento X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.